Delivery Order SPE2DB20D1050-SPE2DB25FH90V
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,604.88 to AmerisourceBergen Drug Corp for the supply of Testosterone 50 mg/5 gram gel in unit dose 5-gram packages. This firm fixed-price delivery order was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,390.60 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Testosterone 50 mg/5 gram gel in unit dose 5 gram packages. This is a non-set-aside competitive award with an ultimate completion date of September 15, 2025. AmerisourceBergen Drug Corp will perform the contract at its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's...
- The Defense Logistics Agency awarded a $1,337.40 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Testosterone 50 mg/5 gram gel in unit dose 5 gram packages, with a completion date of September 5, 2025. This delivery order is issued under a firm fixed price structure with no set-aside designation, reflecting a competitive award to the prime contractor. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.10 to AmerisourceBergen Drug Corp for the supply of Testosterone 50 mg/5 gram gel in unit dose 5 gram packages. The contract, which is firm fixed price and non-set-aside, was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Testosterone 1% (50 mg/5g) in unit dose 5-gram packets. This delivery order, valued at $1,112.22 with a firm fixed price structure, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award is non-competitive and designated for performance at the contractor's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams. This competitively awarded, non-set-aside contract carries a ceiling value of $1,493.80 and represents a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,466.98 on September 3, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packages of 5 grams. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $1,428.90 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a $2,415.13 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose 5-gram packets. The contract employs firm fixed pricing with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The order is scheduled for completion by September 4, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Testosterone 50 mg/5 gram packets (unit dose, 5 grams) with a ceiling value of $1,010.68. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for ultimate completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH90VDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Testosterone 50 mg/5 gram gel in unit dose 5-gram packages, with a contract ceiling value of $1,419.56 and a firm fixed price structure. The delivery order is set to be completed by September 15, 2025, and represents fulfillment under AmerisourceBergen's existing indefinite delivery vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems across the Defense Health Agency, U.S. Coast Guard, and other government entities. This delivery order was competitively awarded with no set-aside designation and falls under AmerisourceBergen's comprehensive DLA Troop Support Medical indefinite delivery contract (SPE2DX), valued at $999,999,999.00 through December 2026. The parent contract serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements, from small-value transactions to substantial orders, positioning the company as a key supplier within DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/12/25 |